Although pneumococcal vaccine is recommended by the National Health and Med
ical Research Council and is cost-effective in preventing invasive pneumoco
ccal disease, it is the only vaccine on the standard schedule that is not n
ationally funded through public health grants to the States.
In Victoria, the Department of Human Services has provided free pneumococca
l vaccine to people aged 65 years and over since 1998.
Pneumococcal vaccination was given in conjunction with the annual influenza
vaccination program; 28.5% of the eligible cohort (95% CI, 24.8%-32.1%) re
ceived pneumococcal vaccine in 1998, giving an estimated cumulative coverag
e of 42% (13.4% had received it in 1997).
We expect coverage will continue to increase over time, but revaccination e
very five years will present a substantial financial burden; access to vacc
ine is critical to improving coverage.
Our experience in Victoria suggests that a nationally funded program, admin
istered similarly to the influenza vaccination program, would dramatically
increase pneumococcal vaccination coverage at a national level.